← Browse by Condition
Medical Condition

hepatitis c virus hcv

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for hepatitis c virus hcv sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Top Sponsors
AbbVie 1 trial
University of California, Los Angeles 1 trial
McGill University Health Centre/Research Institute of the McGill University Health Centre 1 trial

Recruiting Clinical Trials

NCT07419347
Recruiting

Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

Enrollment
2,000 pts
Location
Canada
Sponsor
AbbVie
View Trial →
NCT07433985
Recruiting

California MEPS Hub

Enrollment
318 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →
NCT07122219
Recruiting

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Enrollment
548 pts
Location
Canada
Sponsor
McGill University Health Centr...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology